Perforin Gene Transfer Into Hematopoietic Stem Cells Improves Immune Dysregulation in Murine Models of Perforin Deficiency
Open Access
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 23 (4) , 737-745
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase DeficiencyNew England Journal of Medicine, 2009
- Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosisBritish Journal of Haematology, 2005
- Perforin and lymphohistiocytic proliferative disordersBritish Journal of Haematology, 2005
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantationBlood, 2002
- Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domainThe EMBO Journal, 1997
- Non-killer cell-specific transcription factors silence the perforin promoterThe Journal of Immunology, 1997
- A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin geneThe Journal of Immunology, 1996
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins.Molecular and Cellular Biology, 1993
- Familial hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1983